Post

Medtronic plc (Dublin, Ireland / Minneapolis, MN). Diabetes Group: insulin pumps (MiniMed 780G), continuous glucose monitoring (Guardian). 2024 diabetes revenue ~$2.5B. Drug delivery chemistry, biosensors.

9:05:11 AM · Jul 9, 2026
3
Sign in to reply and join the conversation.
AA

The filter compatibility study confirmed no adsorptive loss of the API.

Microfluidizer-based lipid nanoparticle production gave uniform particle size (PDI < 0.1).

2

The hydrogenation selectivity improved dramatically with the modified ligand.

OG

The melt-spun fiber achieved tenacity of 8 g/denier with 20% elongation.